Levin Capital Strategies, L.P. Laboratory Corp Of America Holdings Transaction History

Levin Capital Strategies, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	SELL	$211.93 - $241.33 $860,435 - $979,799	-4,060 Reduced 4.77%	80,997 $19.5 Million
Q1 2023 Apr 24, 2023	BUY	$213.32 - $257.83 $18.1 Million - $21.9 Million	85,057 New	85,057 $19.5 Million
Q4 2021 Feb 15, 2022	SELL	$271.6 - $314.21 $248,514 - $287,502	-915 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$204.88 - $255.03 $187,465 - $233,352	915 New	915 $233,000
Q4 2018 Feb 05, 2019	SELL	$120.82 - $174.09 $2.05 Million - $2.96 Million	-17,000 Closed	0 $0
Q3 2018 Oct 29, 2018	SELL	$167.67 - $188.27 $335,340 - $376,540	-2,000 Reduced 10.53%	17,000 $2.95 Million
Q2 2018 Aug 07, 2018	SELL	$160.33 - $189.41 $344,709 - $407,231	-2,150 Reduced 10.17%	19,000 $3.41 Million
Q1 2018 May 18, 2018	BUY	$161.53 - $178.11 $3.17 Million - $3.5 Million	19,650 Added 1310.0%	21,150 $3.42 Million
Q4 2017 Feb 09, 2018	BUY	$147.99 - $163.95 $221,985 - $245,924	1,500	1,500 $239,000

1.87M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $22.8B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Levin Capital Strategies, L.P., based on Form 13F filings with the SEC.

Stay updated on Levin Capital Strategies, L.P. with notifications on news.